from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0842/-

LFCtreatmentdescriptionclass of inhibitor

0.645

Amikacinug/mL Amikacintranslation

-0.303

Cap5-10ug/mL Capreomycintranslation

0.306

Rox10-50 ug/mL Roxithromycintranslation

1.078

SM2-5 ug/mL Streptomycintranslation

2.576

Tet5-10 ug/mL Tetracyclinetranslation

1.416

Rif0.2-5ug/mL Rifampicintranscription

0.584

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.879

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.492

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.832

CPZ10-50 ug/mL Chlorpromazinerespiration

1.045

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.313

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.709

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.715

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.243

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.398

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.767

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.738

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.456

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.365

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.471

Nigericin50 uM Nigericinrespiration

0.222

TRC10-150 ug/mL Triclosanrespiration

0.185

TRZ10-25 ug/mL Thioridazinerespiration

-1.041

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.854

menadione6-10 ug/mL Menadionerespiration

-0.647

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.254

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.233

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.470

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.857

NRP_1Non-replicating persistence stage 1dosRassociated

-0.031

Amp0.2mg/mL AmpicillincellWall

0.352

Cephalexin20-100 ug/mL CephalexincellWall

-0.407

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.090

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.044

EMB10-20 ug/mL EthambutolcellWall

0.763

Eta12-40 ug/mL EthionamidecellWall

-0.245

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.234

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.836

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.166

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.279

BZA0.12 mg/mL BenzamidearomaticAmides

0.182

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.419

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.326

H2O24 mM hydrogen peroxideDNAdamaging

-0.125

Levo10 ug/mL LevofloxacinDNAdamaging

0.452

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.251

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.277

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.081

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.664

Antimycin12.5-50 ug/mL Antimycin A?

-0.551

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.196

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.316

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.150

PA8240.2-2 ug/mL PA-824?

0.201

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.210

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.215

Verapamil50 uM Verapamil?

-0.976

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.232

methoxatin10-20 ug/mL Methoxatin?